| pubmed-article:7789082 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7789082 | lifeskim:mentions | umls-concept:C0064636 | lld:lifeskim |
| pubmed-article:7789082 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:7789082 | lifeskim:mentions | umls-concept:C0022277 | lld:lifeskim |
| pubmed-article:7789082 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:7789082 | pubmed:dateCreated | 1995-7-24 | lld:pubmed |
| pubmed-article:7789082 | pubmed:abstractText | LTG, lamotrigine is a new antiepileptic agent chemically unrelated to any established drugs in use. The safety and the efficacy of LTG (564.5 +/- 74.4) mg/day was evaluated as add-on therapy (plus CBZ) in a placebo controlled study of 34 patients with refractory partial complex and/or partial secondary generalized seizures. The incidence of adverse effects of the drug is low and the unwanted effects are reversible. The long half-life and lack of effect on other AEDs will render LTG an easily dosable addiction to a patient's existing regimen. Reduction in the total number seizures was recorded in 61.4% of patients. We conclude that LTG is an effective AED for treatment of therapy-resistant partial seizure. | lld:pubmed |
| pubmed-article:7789082 | pubmed:language | ita | lld:pubmed |
| pubmed-article:7789082 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7789082 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7789082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7789082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7789082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7789082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7789082 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7789082 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:7789082 | pubmed:issn | 0009-9074 | lld:pubmed |
| pubmed-article:7789082 | pubmed:author | pubmed-author:SopranziNN | lld:pubmed |
| pubmed-article:7789082 | pubmed:author | pubmed-author:de RomanisFF | lld:pubmed |
| pubmed-article:7789082 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7789082 | pubmed:volume | 146 | lld:pubmed |
| pubmed-article:7789082 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7789082 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7789082 | pubmed:pagination | 203-9 | lld:pubmed |
| pubmed-article:7789082 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:meshHeading | pubmed-meshheading:7789082-... | lld:pubmed |
| pubmed-article:7789082 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7789082 | pubmed:articleTitle | [Lamotrigine: first experience in Italy]. | lld:pubmed |
| pubmed-article:7789082 | pubmed:affiliation | Dipartimento di Scieze Neurologiche, Università degli Studi di Roma La Sapienza. | lld:pubmed |
| pubmed-article:7789082 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7789082 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7789082 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:7789082 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
